Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types.

Durham DP, Poolman EM, Ibuka Y, Townsend JP, Galvani AP.

J Infect Dis. 2012 Oct;206(8):1291-8. Epub 2012 Aug 7.

PMID:
22872732
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.

Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E.

Int J Cancer. 2003 Oct 10;106(6):896-904.

PMID:
12918067
[PubMed - indexed for MEDLINE]
3.

Exploring individual HPV coinfections is essential to predict HPV-vaccination impact on genotype distribution: a model-based approach.

Pons-Salort M, Letort V, Favre M, Heard I, Dervaux B, Opatowski L, Guillemot D.

Vaccine. 2013 Feb 6;31(8):1238-45. doi: 10.1016/j.vaccine.2012.11.098. Epub 2012 Dec 13.

PMID:
23246257
[PubMed - indexed for MEDLINE]
4.

Impact of vaccine protection against multiple HPV types on the cost-effectiveness of cervical screening.

Coupé VM, Bogaards JA, Meijer CJ, Berkhof J.

Vaccine. 2012 Feb 27;30(10):1813-22. doi: 10.1016/j.vaccine.2012.01.001. Epub 2012 Jan 10.

PMID:
22240341
[PubMed - indexed for MEDLINE]
5.

Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.

Figueroa JP, Ward E, Luthi TE, Vermund SH, Brathwaite AR, Burk RD.

Sex Transm Dis. 1995 Mar-Apr;22(2):114-8.

PMID:
7624812
[PubMed - indexed for MEDLINE]
6.

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada.

Kohli M, Lawrence D, Haig J, Anonychuk A, Demarteau N.

BMC Public Health. 2012 Oct 13;12:872. doi: 10.1186/1471-2458-12-872.

PMID:
23061913
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.

Marty R, Roze S, Bresse X, Largeron N, Smith-Palmer J.

BMC Cancer. 2013 Jan 8;13:10. doi: 10.1186/1471-2407-13-10.

PMID:
23298365
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Vaccination and the evolutionary ecology of human papillomavirus.

Poolman EM, Elbasha EH, Galvani AP.

Vaccine. 2008 Jul 18;26 Suppl 3:C25-30.

PMID:
18773535
[PubMed - indexed for MEDLINE]
9.

Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the Netherlands.

Lenselink CH, Melchers WJ, Quint WG, Hoebers AM, Hendriks JC, Massuger LF, Bekkers RL.

PLoS One. 2008;3(11):e3743. doi: 10.1371/journal.pone.0003743. Epub 2008 Nov 17.

PMID:
19011683
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.

Kovács K, Varnai AD, Bollmann M, Bankfalvi A, Szendy M, Speich N, Schmitt C, Pajor L, Bollmann R.

J Med Virol. 2008 Oct;80(10):1814-23. doi: 10.1002/jmv.21282.

PMID:
18712836
[PubMed - indexed for MEDLINE]
11.

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.

Westra TA, Stirbu-Wagner I, Dorsman S, Tutuhatunewa ED, de Vrij EL, Nijman HW, Daemen T, Wilschut JC, Postma MJ.

BMC Infect Dis. 2013 Feb 7;13:75. doi: 10.1186/1471-2334-13-75.

PMID:
23390964
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Immunity to oncogenic human papillomaviruses.

Konya J, Dillner J.

Adv Cancer Res. 2001;82:205-38. Review.

PMID:
11447764
[PubMed - indexed for MEDLINE]
13.

Aggregation and competitive exclusion: explaining the coexistence of human Papillomavirus types and the effectiveness of limited vaccine conferred cross-immunity.

Waters EK.

Acta Biotheor. 2012 Dec;60(4):333-56. doi: 10.1007/s10441-012-9161-5. Epub 2012 Jun 30.

PMID:
22752424
[PubMed - indexed for MEDLINE]
14.

Why consider human papillomavirus vaccination in older women?

Poppe WA, Simon PH, De Ridder MR.

Gynecol Obstet Invest. 2010;70(4):237-43. doi: 10.1159/000314012. Epub 2010 Oct 16.

PMID:
21051842
[PubMed - indexed for MEDLINE]
15.

Vaccination against multiple HPV types.

Elbasha EH, Galvani AP.

Math Biosci. 2005 Sep;197(1):88-117.

PMID:
16095627
[PubMed - indexed for MEDLINE]
16.

Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany.

Petry KU, Luyten A, Justus A, Iftner A, Strehlke S, Reinecke-Lüthge A, Grunwald E, Schulze-Rath R, Iftner T.

BMC Infect Dis. 2013 Mar 13;13:135. doi: 10.1186/1471-2334-13-135.

PMID:
23497108
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination.

Trottier H, Mahmud S, Prado JC, Sobrinho JS, Costa MC, Rohan TE, Villa LL, Franco EL.

J Infect Dis. 2008 May 15;197(10):1436-47. doi: 10.1086/587698.

PMID:
18419547
[PubMed - indexed for MEDLINE]
Free Article
18.

Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of China.

Chen Q, Xie LX, Qing ZR, Li LJ, Luo ZY, Lin M, Zhang SM, Chen WZ, Lin BZ, Lin QL, Li H, Chen WP, Zheng PY, Mao LZ, Chen CY, Yang C, Zhan YZ, Liu XZ, Zheng JK, Yang LY.

PLoS One. 2012;7(2):e32149. doi: 10.1371/journal.pone.0032149. Epub 2012 Feb 24.

PMID:
22384160
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The theoretical population-level impact of a prophylactic human papilloma virus vaccine.

Hughes JP, Garnett GP, Koutsky L.

Epidemiology. 2002 Nov;13(6):631-9.

PMID:
12410003
[PubMed - indexed for MEDLINE]
20.

Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.

Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P, Depuydt C.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):321-30. doi: 10.1158/1055-9965.EPI-08-0510.

PMID:
19124515
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk